Breaking News Instant updates and real-time market news.

NTGN

Neon Therapeutics

$1.64

0.42 (34.43%)

, BNTX

BioNTech

$33.25

-1.15 (-3.34%)

11:26
01/16/20
01/16
11:26
01/16/20
11:26

Neon Therapeutics downgraded to Neutral from Outperform at Baird

Baird analyst Madhu Kumar downgraded Neon Therapeutics to Neutral from Outperform with a price target of $2, down from $15.00. BioNTech (BNTX) and Neon Therapeutics announced earlier that they have entered into a definitive merger agreement under which BioNTech will acquire Neon in an all-stock transaction valued at approximately $67M.

NTGN

Neon Therapeutics

$1.64

0.42 (34.43%)

BNTX

BioNTech

$33.25

-1.15 (-3.34%)

NTGN Neon Therapeutics
$1.64

0.42 (34.43%)

11/26/19
MSCO
11/26/19
DOWNGRADE
Target $1
MSCO
Underweight
Neon Therapeutics downgraded to Underweight from Overweight at Morgan Stanley
Morgan Stanley downgraded Neon Therapeutics to Underweight from Overweight with a $1 price target.
11/26/19
MSCO
11/26/19
DOWNGRADE
Target $1
MSCO
Underweight
Morgan Stanley double downgrades Neon Therapeutics to Underweight
Morgan Stanley analyst Vikram Purohit downgraded Neon Therapeutics to Underweight from Overweight with a price target of $1, down from $13, following the company's recent announcement that it will no longer allocate resources towards the development of cancer vaccine programs NEO-PV-01 and NEO-SV-01. NEO-PV-01 was previously Neon's lead product candidate, noted Purohit, who said the company's newly prioritized neoantigen-targeted T-cell therapy platform is too early in development for him to value given that Phase 1 data is not expected until 2021.
11/27/19
HCWC
11/27/19
DOWNGRADE
HCWC
Neutral
Neon Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju downgraded Neon Therapeutics to Neutral from Buy without a price target. Last week, Neon announced it will be reducing its workforce by approximately 24% and will cease funding additional research and development for its cancer vaccine programs, NEO-PV-01 and NEO-SV-01, the analyst points out. He cites the company's restructuring and strategic shift for the downgrade.
11/27/19
11/27/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. BrightView (BV) downgraded to Hold from Buy at Stifel with analyst Shlomo Rosenbaum saying he points to the company's "erratic performance" over the past year, its "inherent lack of visibility" due to weather related items, and its free cash flow uncertainty due to the Development segment's subprime contractor position. 2. Dollar Tree (DLTR) downgraded to Market Perform from Outperform at Telsey Advisory with analyst Matthew Boss saying the company's Q3 miss and Q4 guidance cut takes it multi-year growth algorithm off the table. 3. Axon (AAXN) downgraded to Market Perform from Strong Buy at Raymond James with analyst Brian Gesuale saying he believes the stock's "unsustainable energetic move higher" this month cannot be reconciled with fundamentals of the business. 4. PVH Corp. (PVH) downgraded to In Line from Outperform at Evercore ISI. 5. Neon Therapeutics (NTGN) downgraded to Neutral from Buy at H.C. Wainwright with analyst Raghuram Selvaraju saying Neon announced it will be reducing its workforce by approximately 24% and will cease funding additional research and development for its cancer vaccine programs, NEO-PV-01 and NEO-SV-01. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
BNTX BioNTech
$33.25

-1.15 (-3.34%)

11/04/19
BREN
11/04/19
INITIATION
Target $25
BREN
Buy
BioNTech initiated with a Buy at Berenberg
Berenberg analyst Shanshan Xu initiated coverage of BioNTech with a Buy rating and $25 price target.
11/04/19
JPMS
11/04/19
INITIATION
Target $23
JPMS
Overweight
BioNTech initiated with an Overweight at JPMorgan
JPMorgan analyst Cory Kasimov initiated coverage of BioNTech with an Overweight rating and $23 price target. The company is taking an immuno-oncology approach to attack cancer and using multiple tools to address the heterogeneous nature of tumor biology, Kasimov tells investors in a research note. He sees a "well-defined catalyst calendar" with BioNTech having at least five programs reading out over the course of 2020.
11/04/19
ADAM
11/04/19
INITIATION
Target $22
ADAM
Buy
BioNTech initiated with a Buy at Canaccord
Canaccord analyst Arlinda Lee initiated coverage of BioNTech with a Buy rating as the company seeks to deliver immunotherapy personalized for each patient's immune system, genetic background, and tumor characteristics. The company has eight clinical drug candidates, six partnerships, and the potential to generate many more therapeutic candidates. Lee has a $22 price target on BioNTech shares.
11/05/19
WOLF
11/05/19
INITIATION
Target $21
WOLF
Outperform
BioNTech initiated with an Outperform at Wolfe Research
Wolfe Research analyst Akash Tewari initiated coverage of BioNTech with an Outperform rating and $21 price target. The analyst said early melanoma data and prior-generation PCV candidate compares favorably to competitor cancer vaccine programs.

TODAY'S FREE FLY STORIES

BRBR

BellRing Brands

$22.71

-0.26 (-1.13%)

17:34
01/22/20
01/22
17:34
01/22/20
17:34
Initiation
BellRing Brands initiated  »

BellRing Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

GVA

Granite Construction

$26.57

-0.19 (-0.71%)

17:32
01/22/20
01/22
17:32
01/22/20
17:32
Hot Stocks
Granite Construction awarded $14M contract by San Bernardino County »

Granite has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GVA

Granite Construction

$26.57

-0.19 (-0.71%)

17:31
01/22/20
01/22
17:31
01/22/20
17:31
Hot Stocks
Granite Construction awarded $14M interesection improvement project in SC »

Granite has been awarded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDLZ

Mondelez

$55.47

-0.1 (-0.18%)

17:31
01/22/20
01/22
17:31
01/22/20
17:31
Initiation
Mondelez initiated  »

Mondelez initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

  • 17

    Feb

BFRA

Biofrontera

$10.89

(0.00%)

17:30
01/22/20
01/22
17:30
01/22/20
17:30
Syndicate
Breaking Syndicate news story on Biofrontera »

Biofrontera files $100M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMPL

Simply Good Foods

$24.96

-0.17 (-0.68%)

17:29
01/22/20
01/22
17:29
01/22/20
17:29
Initiation
Simply Good Foods initiated  »

Simply Good Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

HZNP

Horizon Therapeutics

$38.54

0.28 (0.73%)

17:28
01/22/20
01/22
17:28
01/22/20
17:28
Hot Stocks
NEJM publishes data from Horizon Therapeutics Optic trial of Tepezza »

Horizon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Mar

  • 29

    Apr

CHMG

Chemung Financial

$42.20

(0.00%)

17:26
01/22/20
01/22
17:26
01/22/20
17:26
Earnings
Chemung Financial reports Q4 EPS 87c, consensus $1.04 »

Reports Q4 book value per…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLGX

CoreLogic

$44.99

-0.365 (-0.80%)

17:26
01/22/20
01/22
17:26
01/22/20
17:26
Earnings
CoreLogic sees FY19 free cash flow exceeding 50% of adjusted EBITDA »

CoreLogic said that free…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 09

    Mar

NOMD

Nomad Foods

$20.63

0.075 (0.36%)

17:24
01/22/20
01/22
17:24
01/22/20
17:24
Initiation
Nomad Foods initiated  »

Nomad Foods initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Feb

CCNE

CNB Financial

$31.13

-0.2 (-0.64%)

17:24
01/22/20
01/22
17:24
01/22/20
17:24
Syndicate
Breaking Syndicate news story on CNB Financial »

CNB Financial files $150M…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLGX

CoreLogic

$44.99

-0.365 (-0.80%)

17:24
01/22/20
01/22
17:24
01/22/20
17:24
Earnings
CoreLogic sees FY19 guidance 'modestly' exceeding previous outlook »

CoreLogic said that FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 09

    Mar

CLGX

CoreLogic

$44.99

-0.365 (-0.80%)

17:20
01/22/20
01/22
17:20
01/22/20
17:20
Earnings
Breaking Earnings news story on CoreLogic »

CoreLogic sees Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 09

    Mar

TWNK

Hostess Brands

$13.83

-0.06 (-0.43%)

17:19
01/22/20
01/22
17:19
01/22/20
17:19
Initiation
Hostess Brands initiated  »

Hostess Brands initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

PAYC

Paycom

$303.73

3.96 (1.32%)

, WCG

WellCare

$345.79

5.27 (1.55%)

17:18
01/22/20
01/22
17:18
01/22/20
17:18
Hot Stocks
Paycom to replace WellCare in S&P 500 at open on 1/28 »

Centene (CNC) is…

PAYC

Paycom

$303.73

3.96 (1.32%)

WCG

WellCare

$345.79

5.27 (1.55%)

CNC

Centene

$66.72

1.24 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Feb

  • 13

    Feb

AMRN

Amarin

$20.82

-0.24 (-1.14%)

17:18
01/22/20
01/22
17:18
01/22/20
17:18
Hot Stocks
Amarin says payers response on new Vascepa indication 'very positive' »

In a statement to the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAFD

Washington Federal

$35.35

-0.32 (-0.90%)

17:17
01/22/20
01/22
17:17
01/22/20
17:17
Hot Stocks
Washington Federal increases quarterly cash dividend 5% to 22c per share »

The board of Washington…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jan

  • 24

    Feb

FBNC

First Bancorp

$37.42

-0.37 (-0.98%)

17:16
01/22/20
01/22
17:16
01/22/20
17:16
Earnings
First Bancorp reports Q4 EPS 71c, consensus 78c »

Net interest income for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

THS

TreeHouse

$46.83

-0.085 (-0.18%)

17:12
01/22/20
01/22
17:12
01/22/20
17:12
Initiation
TreeHouse initiated  »

TreeHouse assumed with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Feb

  • 17

    Feb

LW

Lamb Weston

$91.19

0.01 (0.01%)

17:11
01/22/20
01/22
17:11
01/22/20
17:11
Initiation
Lamb Weston initiated  »

Lamb Weston assumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

RP

RealPage

$57.51

-0.29 (-0.50%)

17:10
01/22/20
01/22
17:10
01/22/20
17:10
Hot Stocks
RealPage to acquire Modern Message, terms not disclosed »

RealPage has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Feb

TER

Teradyne

$73.57

2.04 (2.85%)

17:10
01/22/20
01/22
17:10
01/22/20
17:10
Hot Stocks
Teradyne up 8% after Q4 earnings beat and above-consensus Q1 outlook »

Shares of Teradyne are up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

HAIN

Hain Celestial

$25.48

(0.00%)

17:10
01/22/20
01/22
17:10
01/22/20
17:10
Initiation
Hain Celestial initiated  »

Hain Celestial assumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TER

Teradyne

$73.57

2.04 (2.85%)

17:07
01/22/20
01/22
17:07
01/22/20
17:07
Hot Stocks
Teradyne CEO says Q1 outlook reflects the impact of customer production ramps »

CEO Mark Jagiela states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

OSBC

Old Second Bancorp

$13.21

0.14 (1.07%)

17:07
01/22/20
01/22
17:07
01/22/20
17:07
Earnings
Breaking Earnings news story on Old Second Bancorp »

Old Second Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.